Clinical trial
Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab
NCT04119921 is registered in ClinicalTrials.gov with Shahid Beheshti University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab
- Lead sponsor
- Shahid Beheshti University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- June 20, 2020
- Enrollment
- 26 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dme